Form 4: Verrica Pharmaceuticals CFO Terry Kohler Sells Shares to Cover Tax Obligations

Verrica Pharmaceuticals' CFO, Terry Kohler, sold shares of common stock to cover statutory tax withholding obligations related to the settlement of restricted stock units.

Summary

• On August 26, 2024, Terry Kohler, the CFO of Verrica Pharmaceuticals, sold 21,820 shares of common stock at a weighted average price of $2.66.
• The shares were sold in multiple transactions with prices ranging from $2.53 to $2.83.
• On August 27, 2024, Kohler sold an additional 7,899 shares at a weighted average price of $2.46.
• These shares were sold in multiple transactions with prices ranging from $2.40 to $2.53.
• These sales were mandated by Verrica Pharmaceuticals' equity incentive plan to cover statutory tax withholding obligations and do not represent discretionary sales by Kohler.
• Following these transactions, Kohler directly owns 44,697 shares of Verrica Pharmaceuticals.

Sentiment

Score: 5

Explanation: The document reflects a routine transaction (stock sale to cover taxes) and doesn't inherently indicate positive or negative sentiment about the company's prospects.

Industry Context

Form 4 filings are standard practice and provide transparency into the transactions of company insiders. These filings are closely monitored by investors to gauge management's sentiment and potential future performance of the company.

Stakeholder Impact

• The stock sales could have a minor impact on shareholders due to the increased supply of shares in the market, but the impact is likely minimal given the reason for the sale.

Key Dates